Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) shares were down 0.9% during trading on Tuesday . The stock traded as low as $19.70 and last traded at $19.7752. Approximately 137,067 shares traded hands during trading, a decline of 20% from the average daily volume of 171,414 shares. The stock had previously closed at $19.95.
Wall Street Analysts Forecast Growth
Separately, Zacks Research cut Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.
Read Our Latest Analysis on SMMNY
Siemens Healthineers Stock Performance
Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02. The company had revenue of $6.68 billion during the quarter, compared to analysts’ expectations of $6.96 billion.
About Siemens Healthineers
Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.
The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.
Featured Articles
- Five stocks we like better than Siemens Healthineers
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
